Clinical trials
Phase 3 trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
215 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 8 |
| 2019 | 11 |
| 2020 | 18 |
| 2021 | 13 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 16 |
| 2025 | 20 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 137 |
| Unknown status | 33 |
| Recruiting | 24 |
| Not yet recruiting | 8 |
| Active, not recruiting | 5 |
| Terminated | 4 |
| Enrolling by invitation | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aga Khan University | 19 |
| GlaxoSmithKline | 15 |
| NICHD Global Network for Women's and Children's Health | 6 |
| Bayer | 5 |
| Dow University of Health Sciences | 5 |
| King Edward Medical University | 5 |
| London School of Hygiene and Tropical Medicine | 5 |
| Novartis Pharmaceuticals | 5 |
| Population Health Research Institute | 5 |
| International Atomic Energy Agency | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 17 |
| Breast Neoplasms | 9 |
| Anemia | 6 |
| Hepatitis C | 6 |
| Hepatitis D | 5 |
| Postoperative Pain | 5 |
| Hemorrhage | 4 |
| Hepatitis C, Chronic | 4 |
| Hypertension | 4 |
| Neonatal Sepsis | 4 |
Trials
Showing 76 to 100 of 215. Each trial links to its page on Pharma Observatory.
115 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.